Mario Udovicic

Zagreb, 10000, Croatia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Heart Failure Etiology and 6-Month Cardiorenal Recovery Patterns After Early In-Hospital SGLT2 Inhibitor Initiation in HFrEF: A Prospective Real-World Cohort.

Heart Failure Etiology and 6-Month Cardiorenal Recovery Patterns After Early In-Hospital SGLT2 Inhibitor Initiation in HFrEF: A Prospective Real-World Cohort.

Journal: Medicina (Kaunas, Lithuania)

Published: April 15, 2026

Two-Year Implementation, Adherence, and Outcomes of Quadruple Guideline-Directed Medical Therapy in Newly Diagnosed HFrEF: Insights from the Prospective CaRD Registry.

Two-Year Implementation, Adherence, and Outcomes of Quadruple Guideline-Directed Medical Therapy in Newly Diagnosed HFrEF: Insights from the Prospective CaRD Registry.

Journal: Journal of clinical medicine

Published: February 19, 2026

Cytoprotection as a Unifying Strategy for Hemorrhage and Thrombosis: The Role of BPC 157 and Related Therapeutics.

Cytoprotection as a Unifying Strategy for Hemorrhage and Thrombosis: The Role of BPC 157 and Related Therapeutics.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: February 17, 2026

Conventional Antiarrhythmics Class I-IV, Late INa Inhibitors, IKs Enhancers, RyR2 Stabilizers, Gap Junction Modulators, Atrial-Selective Antiarrhythmics, and Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Therapy in Arrhythmias.

Conventional Antiarrhythmics Class I-IV, Late INa Inhibitors, IKs Enhancers, RyR2 Stabilizers, Gap Junction Modulators, Atrial-Selective Antiarrhythmics, and Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Therapy in Arrhythmias.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: December 30, 2025

National Utilization and Expenditure Trends of GLP-1 Receptor Agonists and Dual GLP-1/GIP Agonist in Croatia, 2017-2024.

National Utilization and Expenditure Trends of GLP-1 Receptor Agonists and Dual GLP-1/GIP Agonist in Croatia, 2017-2024.

Journal: Medicina (Kaunas, Lithuania)

Published: November 19, 2025

Prevalence and factors associated with potential clinically significant drug-drug interactions in patients with cardiovascular diseases at hospital admission.

Prevalence and factors associated with potential clinically significant drug-drug interactions in patients with cardiovascular diseases at hospital admission.

Journal: Acta pharmaceutica (Zagreb, Croatia)

Published: November 18, 2024

Effects of Sodium-Glucose Co-Transporter 2 Inhibitors on Serum Chloride Concentrations in Patients with Heart Failure.

Effects of Sodium-Glucose Co-Transporter 2 Inhibitors on Serum Chloride Concentrations in Patients with Heart Failure.

Journal: Journal of cardiovascular development and disease

Published: September 13, 2024

A COVERED CORONARY STENT FOR ACUTE PERFORATION AFTER A PERCUTANEOUS CORONARY INTERVENTION DUE TO CARDIAC ALLOGRAFT VASCULOPATHY.

A COVERED CORONARY STENT FOR ACUTE PERFORATION AFTER A PERCUTANEOUS CORONARY INTERVENTION DUE TO CARDIAC ALLOGRAFT VASCULOPATHY.

Journal: Acta clinica Croatica

Published: March 01, 2024

STENT CATHETER TOO SHORT TO SOLVE A BIZZARE STENT EMBOLIZATION: WHAT TO DO?

STENT CATHETER TOO SHORT TO SOLVE A BIZZARE STENT EMBOLIZATION: WHAT TO DO?

Journal: Acta clinica Croatica

Published: March 01, 2024

Heart failure in patients is associated with downregulation of mitochondrial quality control genes.

Heart failure in patients is associated with downregulation of mitochondrial quality control genes.

Journal: European journal of clinical investigation

Published: February 19, 2023

Longitudinal analysis of chest Q-SPECT/CT in patients with severe COVID-19.

Longitudinal analysis of chest Q-SPECT/CT in patients with severe COVID-19.

Journal: Respiratory medicine

Published: February 07, 2023

Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Peptide Therapy in the Heart Disturbances, Myocardial Infarction, Heart Failure, Pulmonary Hypertension, Arrhythmias, and Thrombosis Presentation.

Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Peptide Therapy in the Heart Disturbances, Myocardial Infarction, Heart Failure, Pulmonary Hypertension, Arrhythmias, and Thrombosis Presentation.

Journal: Biomedicines

Published: September 11, 2022

Showing 1-12 of 28

Last Updated: 09/26/2026